Home | Projects |

CCN Reasearch Center Project Finance Fac

Türkiye | Health Care

Identification Code:: OP/16/0048
Total Operation Cost:: 711.000.000 EUR
Maturity:: 180 months
Operation Status:: BSTDB Approved Amount – Approval Date

30.000.000 EUR – 01 Jul 2017
: BSTDB Signed Amount – Signed Date

-50.000.000 EUR – 28 Dec 2018

50.000.000 EUR – 28 Dec 2017
: Status:
Cancelled
Description and Purpose of the Operation:: Provision of a project finance facility to a special purpose vehicle, CCN Laboratuar Hizmetleri ve Yoneticm Anonim Sirketi, Turkey, to design, finance, construct, operate and transfer a medical research center with 4 different biosafety level laboratories, through Public Private Partnership ("PPP") model.
Countries of Operation:: Türkiye (100,00%)
Financial Product:: Loans
Sector:: Health Care
Domain:: Public
Borrower/Client:: CCN Laboratuvar Hizmetleri ve Yonetim A.S.,Turkey
Co-Financers/Participants:: BSTDB with A loan and B loan (OFID) facilities BSTDB Parallel lenders: Austrian Development Bank (OeEB) and ECO Trade and Development Bank(ETDB) EBRD with A loan and B loan (Unicredit, Siemens Bank) facilities Islamic Development Bank (IDB) with A loan and B loan (Kuveyt Turk) facilities Islamic Cooperation for the Development of the Private Sector (ICD) QNB Finansbank
Guarantors/Sponsors:: Sponsor: CCN Yatirim Holding A.S., Turkey
Developmental and Regional Cooperation Impact:: The Project is expected to have positive economic benefits for the region, and the Turkish economy more both during the construction phase, as well as during the operational phase. The most relevant of these are new employment creation, demonstration effects, upstream linkages with suppliers, a favorable multiplier effect in the region, and most importantly improved and expanded provision of health care for the public.
Environmental Classification and Impact:: According to IFC, EBRD, EIB, BSTDB and Equator Principles III categorizations the Project is likely to fall into category B (B+ for BSTDB). The categorization is not final and will be confirmed at a later stage. ESDD will be carried out by the LTA and will include a review of the design and operational standards of containment areas and laboratories in order to confirm compliance with WHO guidelines for bio- safety. All the key E&S issues will be addressed through a project- specific ESAP.
Operation Leader:: General Industries, Transport, Tourism 2
E-mail:: gitt2@bstdb.org